LANGER; Gernot

Patent Applications and Registrations

Patent applications and USPTO patent grants for LANGER; Gernot.The latest application filed is for "inhibitors and antagonists of gpr84 for the treatment of endometriosis".

Company Profile

0.6.20

LANGER; Gernot - Falkensee DE
Langer; Gernot - Katzelsdorf AT
Langer; Gernot - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors And Antagonists Of Gpr84 For The Treatment Of Endometriosis App 20210401823 - SACHER; Frank ; et al.	2021-12-30
Benzimidazole derivatives as EP4 ligands Grant 10,730,856 - Peters , et al.	2020-08-04
Benzimidazole derivatives as EP4 antagonists Grant 9,708,311 - Peters , et al. July 18, 2	2017-07-18
Methods and apparatus for associating dictation with an electronic record Grant 9,691,385 - Neubacher , et al. June 27, 2	2017-06-27
Novel Benzimidazole Derivatives As Ep4 Antagonists App 20160214977 - PETERS; Olaf ; et al.	2016-07-28
Spiroindoline Derivatives For Use As Gonadotropin-releasing Hormone Receptor Antagonists App 20160052936 - PANKNIN; Olaf ; et al.	2016-02-25
Methods And Apparatus For Associating Dictation With An Electronic Record App 20150371637 - Neubacher; Andreas ; et al.	2015-12-24
Indolylamides as modulators of the EP2 receptor App 20100029599 - Koppitz; Marcus ; et al.	2010-02-04
Extended Benzamide Derivatives as Modulators of the EP2 Receptor App 20100029598 - Kopitz; Marcus ; et al.	2010-02-04
9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments Grant 7,563,924 - Buchmann , et al. July 21, 2	2009-07-21
Thienopyrimidylamines As Modulators Of The Ep2 Receptor App 20090042878 - BRAEUER; Nico ; et al.	2009-02-12
Substituted Acetamides As Modulators Of The Ep2 Receptor App 20090042882 - BUCHMANN; Bernd ; et al.	2009-02-12
Diaminopyrimidines As Modulators Of The Ep2 Receptor App 20090023738 - Braeuer; Nico ; et al.	2009-01-22
Aryl/hetarylamides As Modulators Of The Ep2 Receptor App 20090023741 - Buchmann; Bernd ; et al.	2009-01-22
N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators App 20080146576 - Braeuer; Nico ; et al.	2008-06-19
N-(1-hetarylpiperidin-4-yl)(het)arylamides as EP2 receptor modulators App 20080125463 - Braeuer; Nico ; et al.	2008-05-29
1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the EP2 receptor App 20080125435 - Brauer; Nico ; et al.	2008-05-29
Inhibitors Of Soluble Adenylate Cyclase App 20080004268 - NGUYEN; Duy ; et al.	2008-01-03
9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments App 20070203096 - Buchmann; Bernd ; et al.	2007-08-30
Fluorenes and carbazoles as ligands of the EP2 receptor App 20070197524 - Brauer; Nico ; et al.	2007-08-23
Acyltryptophanols App 20070060573 - Wortmann; Lars ; et al.	2007-03-15
In Vitro screening for ligands of the estrogen receptor Grant 7,166,438 - Patchev , et al. January 23, 2	2007-01-23
Verification of translation App 20050227951 - Steinmeyer, Andreas ; et al.	2005-10-13
In vitro screening for ligands of the estrogen receptor App 20030087303 - Patchev, Vladimir ; et al.	2003-05-08
Vitamin D derivatives with phosphorus atoms in the side chains Grant 6,531,459 - Steinmeyer , et al. March 11, 2	2003-03-11
New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents App 20030018194 - Steinmeyer, Andreas ; et al.	2003-01-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.